Additionally, analysis of three AML and three ALL single-cell datasets from the TISCH2 database (http://tisch.comp-genomics.org/) showed that RNF220 expression was generally higher in malignant cells compared to other cell types, and this trend was more evident in AML (Supplementary Figures S2a–f). This evidence concerns the gene RNF220 and acute myeloid leukemia.